Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Parecoxib Sodium for Injection

Approval Number

国药准字H20203212

Company四川宏明博思药业有限公司

Registration Date

May 20, 2020

Drug Information

Generic Name

注射用帕瑞昔布钠

Dosage Form

注射剂

Strength

40mg(按C19H18N2O4S计)

Drug Type

化学药品

Registration Date

May 20, 2020

Company Information

Applicant Company

Company Name四川宏明博思药业有限公司

Company Address

成都高新区合作路343号

Manufacturing Company

Company Name四川宏明博思药业有限公司

Company Address

成都高新区合作路343号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy